By integrating proteomic and transcriptomics profiles of GC and PM samples, we reported that APOC2 cooperated with CD36 to regulate EMT process via PI3K/AKT/mTOR signaling, which eventually promoted tumor progression and PM in GC. The gene discussed is CD36; the disease is neoplasm.